|
THIAZIDE DIURETICS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
THIAZIDE DIURETICS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
CORTICOSTEROIDS TEND TO PRODUCE HYPERGLYCEMIA LEADING TO LOSS OF DIABETES CONTROL
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
BOTH HYPO AND HYPERGLYCEMIC EFFECTS HAVE BEEN REPORTED RARELY ; POSSIBILITY EXISTS THAT DICLOFENAC MAY ALTER PATIENTS RESPONSE TO ORAL HYPOGLYCEMIC AGENTS
|
SIGNS OF HYPOGLYCEMIA MAY BE REDUCED OR ABSENT
|
SIGNS OF HYPOGLYCEMIA MAY BE REDUCED OR ABSENT
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|